16:02 Dec 20
Zydus Lifesciences Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Zydus Lifesciences Ltd.
86/100 High Financial Strength
Quality48/100 Mid Valuation
Valuation43/100 Technically Neutral
TechnicalSWOT
Strength
6
Weakness
3
Opportunity
1
Threat
1
97.96K
Market Cap (Cr)
22.07
PE Ratio
4.49
Price to Book Ratio
47.78
RSI
19.74 %
Net Profit Margin
Rating Based on 5 Analysts
Buy
40%
Hold
60%
Sell
0%
Hold
Analyst Price Target
The average price target is 1158 with a high estimate of 1305 and low estimate of 1010
Current 973.50
Disclaimer:The analysis information is for reference only and does not constitude an investment recommendation
SWOT
Download Our App On:
